Loading
Only a handful of insider records exist for Bionomics Ltd/ADR, the last one from 7 October 2024, too few to describe a trend. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
1 of 1 declaration
Bionomics Ltd is a biopharmaceutical company focused on developing treatments for central nervous system disorders and anxiety-related diseases. It is listed on NASDAQ under the symbol BNOX.